Preferred
(EDT)
Other
Novel Therapeutics
Mechanisms of Resistance to Combined Inhibition of RAS Signaling plus Autophagy in Pancreatic Cancer
9:00 AM - 9:25 AM EDT
Thursday, June 24, 2021Speaker
Martin McMahon, PhD
University of Utah School of Medicine
Novel Therapeutics
Targeting Protein Kinases in Cancer
9:25 AM - 9:50 AM EDT
Thursday, June 24, 2021Speaker
Klaus Hoeflich, PhD
Nested Bio
Novel Therapeutics
A General Allele-Specific Model for Understanding and Treating Tumors Driven by ERK-Activation
9:50 AM - 10:15 AM EDT
Thursday, June 24, 2021Speaker
Neal Rosen, MD, PhD
Memorial Sloan-Kettering Cancer Center
Novel Therapeutics
High Dose Vitamin C and Inactivation of DNA Repair Boost Cancer Immunotherapy
10:15 AM - 10:40 AM EDT
Thursday, June 24, 2021Speaker
Alberto Bardelli, PhD
University of Torino
Novel Therapeutics
Short Talk: Regulation of PTEN Translation by PI3K Signaling Maintains Pathway Homeostasis
10:40 AM - 10:55 AM EDT
Thursday, June 24, 2021Speaker
Radha Mukherjee, PhD
Memorial Sloan Kettering
Novel Therapeutics
Short Talk: Oncogenic CCNE1 Amplification Is Synthetic Lethal with PKMYT1 Kinase Inhibition
10:55 AM - 11:10 AM EDT
Thursday, June 24, 2021Speaker
Jordan Young, PhD
Repare Therapeutics, Canada
Novel Therapeutics
